# LeanTaaS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/leantaas

- Industry: Healthcare IT
- Headquarters: Santa Clara, US
- Website: www.leantaas.com
- Total disclosed funding: $200M
- Latest round: Series D (Dec 10, 2020)
- Investors on record: 2

## About

LeanTaaS, Inc. is an innovative technology company specializing in AI-driven solutions for healthcare, enhancing operational efficiency and capacity management for hospitals and ambulatory service providers.Founded in 2010 in Santa Clara, US, LeanTaaS, Inc. provides AI-powered software solutions to optimize healthcare operations. The company was co-founded by Mohan Giridharadas, who is also the current CEO. LeanTaaS raised USD 130.00 mn in Series D funding led by Insight Partners in June 2022, bringing the total amount raised to USD 130.00 mn. The company has completed 11 investment deals to date.LeanTaaS specializes in providing AI-driven solutions aimed at optimizing healthcare capacity management for hospitals and ambulatory service providers. The company’s core offerings include the iQueue solution suite, which leverages predictive analytics, generative AI, and machine learning to enhance operational efficiency across various healthcare settings, including surgical clinics, infusion centers, and inpatient facilities. These products address critical use cases such as managing scheduling, capacity, and staffing needs, reducing patient wait times, and improving overall resource utilization. LeanTaaS serves a wide range of clients, including over 1,200 hospitals and health systems, among which are 14 of the top 25 health systems in the U.S. The company’s products are marketed primarily within the United States, focusing on large healthcare institutions that aim to enhance their operational workflows and patient care experiences.LeanTaaS generates revenue through a subscription-based model for its iQueue solutions, utilized by healthcare organizations to achieve significant returns on investment. Clients benefit from the technology by realizing an estimated USD 100,000 in additional revenue per operating room annually, with similar financial benefits for infusion chairs and inpatient beds. The revenue structure is predominantly B2B, wherein healthcare providers pay for access to the software and associated services that drive capacity management improvements. The company offers a “Transformation as a Service” model, which includes implementation support and ongoing analytics services, ensuring clients can effectively leverage the technology for operational excellence, thus fostering long-term partnerships and maintaining a steady revenue stream while delivering measurable improvements in patient access and workflow efficiency.LeanTaaS plans to leverage its recent acquisition by Bain Capital to further its growth trajectory and enhance its market-leading suite of cloud software solutions. The company aims to expand its product offerings with new releases and enhancements aimed at improving healthcare operational efficiencies. Specific geographic expansion plans are being developed, focusing on broadening its presence in new U.S. markets. The recent funding round will support the development of these initiatives, allowing LeanTaaS to continue innovating and providing valuable solutions to healthcare organizations.

## Funding rounds

- Series D, Dec 10, 2020, $130M — Insight Partners, Goldman Sachs Asset Management
- Series C, Dec 12, 2019, $40M — Insight Partners, Goldman Sachs Asset Management
- Series C, Nov 8, 2018, $15M — Insight Partners
- Series B, Nov 9, 2017, $15M — Insight Partners

## Investors

- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series B, Series C, Series D
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series C, Series D